Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Positron Emission Tomography Using [<sup>18</sup>F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
530
Zitationen
11
Autoren
2000
Jahr
Abstract
This study demonstrates that in patients with advanced breast cancer undergoing primary chemotherapy, FDG-PET differentiates responders from nonresponders early in the course of therapy. This may help improve patient management by avoiding ineffective chemotherapy and supporting the decision to continue dose-intensive preoperative chemotherapy in responding patients.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 29.135 Zit.
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 · 28.510 Zit.
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · 21.376 Zit.
Robust uncertainty principles: exact signal reconstruction from highly incomplete frequency information
2006 · 15.723 Zit.
Image processing with ImageJ
2004 · 11.903 Zit.